Kumar Krishna, Caraway David L, Rizvi Syed, Bishop Sharon
Section of Neurosurgery, Department of Surgery, Regina General Hospital, University of Saskatchewan, Regina, SK, Canada.
Neuromodulation. 2014 Jun;17 Suppl 1:22-35. doi: 10.1111/ner.12172.
This study aims to review the current state of spinal cord stimulation for the treatment of chronic pain associated with failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) and to describe intraspinal targets and stimulation parameters, patient selection, therapy cost-effectiveness, and strategies to improve outcomes.
We drew on professional literature spanning four decades, our work with national and international professional societies, and our own extensive clinical experience to summarize contemporary knowledge of the safety, efficacy, cost-efficiency, and challenges associated with spinal cord stimulation in treating chronic pain.
The safety, efficacy, and cost-efficiency of spinal cord stimulation in treating chronic pain associated with FBSS and CRPS are well established through randomized controlled trials and long-term observational studies. Challenges include reducing wait-times before implant, which are associated with lower success rates; increasing awareness of this therapy among referring physicians, patients, and payers; decreasing device-related complications by incorporating advanced technology, improved operative and trialing techniques, and appropriate patient selection; and capturing functional and quality-of-life outcomes. Spinal cord stimulation must be part of an overall treatment plan to manage chronic pain, and must engage physicians, patients, their families, pharmacists, nursing staff, and mental health experts in supporting a return to employment, if possible, and to a full domestic and social life.
Innovation in spinal cord stimulation therapy has intensified with numerous new technical capabilities, safety advances, and novel stimulation targets. This progress holds hope for the many sufferers of chronic pain.
本研究旨在回顾脊髓刺激疗法治疗与腰椎手术失败综合征(FBSS)和复杂性区域疼痛综合征(CRPS)相关的慢性疼痛的现状,并描述脊髓内刺激靶点、刺激参数、患者选择、治疗成本效益以及改善治疗效果的策略。
我们借鉴了跨越四十年的专业文献、我们与国内和国际专业学会的合作以及我们自身丰富的临床经验,以总结脊髓刺激疗法在治疗慢性疼痛方面的安全性、有效性、成本效益及相关挑战的当代知识。
通过随机对照试验和长期观察性研究,已充分证实脊髓刺激疗法在治疗与FBSS和CRPS相关的慢性疼痛方面的安全性、有效性和成本效益。挑战包括缩短植入前的等待时间(等待时间长与成功率较低相关);提高转诊医生、患者和付款人对该疗法的认知度;通过采用先进技术、改进手术和测试技术以及合理选择患者来减少与设备相关的并发症;以及获取功能和生活质量方面的结果。脊髓刺激疗法必须成为管理慢性疼痛的整体治疗计划的一部分,并且必须让医生、患者及其家属、药剂师、护理人员和心理健康专家参与进来,以支持患者尽可能恢复工作以及回归完整的家庭和社会生活。
随着众多新技术能力、安全性的提高以及新的刺激靶点的出现,脊髓刺激疗法的创新不断加强。这一进展为众多慢性疼痛患者带来了希望。